UnitedHealth Group Inc (UNH) : Acropolis Investment Management reduced its stake in UnitedHealth Group Inc by 5.39% during the most recent quarter end. The investment management company now holds a total of 24,065 shares of UnitedHealth Group Inc which is valued at $3,168,879 after selling 1,370 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on Apr 25, 2016.UnitedHealth Group Inc makes up approximately 0.61% of Acropolis Investment Management’s portfolio.
UnitedHealth Group Inc opened for trading at $132.61 and hit $132.93 on the upside on Monday, eventually ending the session at $132.1, with a gain of 0.32% or 0.42 points. The heightened volatility saw the trading volume jump to 28,87,782 shares. Company has a market cap of $125,584 M.
Other Hedge Funds, Including , Provident Trust Co reduced its stake in UNH by selling 26,811 shares or 2.63% in the most recent quarter. The Hedge Fund company now holds 991,139 shares of UNH which is valued at $130,513,184. UnitedHealth Group Inc makes up approx 7.15% of Provident Trust Co’s portfolio.Nevsky Capital Llp reduced its stake in UNH by selling 372,000 shares or 90.51% in the most recent quarter. The Hedge Fund company now holds 39,000 shares of UNH which is valued at $5,231,070. UnitedHealth Group Inc makes up approx 15.63% of Nevsky Capital Llp’s portfolio.P.r. Herzig reduced its stake in UNH by selling 245 shares or 4.45% in the most recent quarter. The Hedge Fund company now holds 5,255 shares of UNH which is valued at $704,853. UnitedHealth Group Inc makes up approx 1.51% of P.r. Herzig’s portfolio.Capstone Asset Management Co boosted its stake in UNH in the latest quarter, The investment management firm added 1,670 additional shares and now holds a total of 172,548 shares of UnitedHealth Group Inc which is valued at $21,970,537. UnitedHealth Group Inc makes up approx 0.63% of Capstone Asset Management Co’s portfolio.
On the company’s financial health, UnitedHealth Group Inc reported $1.81 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $1.72. The company had revenue of $44527.00 million for the quarter, compared to analysts expectations of $44278.96 million. The company’s revenue was up 24.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.
Many Wall Street Analysts have commented on UnitedHealth Group Inc. Company shares were Reiterated by Mizuho on Apr 20, 2016 to “Buy”, Firm has raised the Price Target to $ 156 from a previous price target of $150 .Company shares were Reiterated by FBR Capital on Apr 19, 2016 to “Outperform”, Firm has raised the Price Target to $ 145 from a previous price target of $130 .Company shares were Reiterated by Mizuho on Mar 15, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $131 .
UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.